FDA Accepts Label Update for Plasma IQ™, the First FDA-Cleared Handheld Plasma Energy Device
The removal of this specific contraindication was due in part [...]
The removal of this specific contraindication was due in part [...]
This new indication enables us to apply Medtronic’s more than [...]
Scott Ward, CSI’s Chairman, President and Chief Executive Officer, said, [...]
“The BD Kiestra IdentifA system transforms the manual workflow into [...]
“The expanded indications of Attrax Putty with thoracolumbar implants support [...]
The Zynex Fluid Monitoring System (CM-1500) is a 100% non-invasive [...]
The R3ACT Stabilization System, expected to commercially launch in early [...]
More than an implant, N1 is a comprehensive system of [...]
“The Breakthrough Device Designation is a significant milestone for our [...]
The FDA Breakthrough Device designation aims to expedite the review [...]